SB1642

Controlled dangerous substances; authorizing divided quantities for certain acute pain opioid prescriptions. Effective date.

Complete·5/7/26

Oklahoma SB1642 amends opioid prescription rules for acute pain, allowing divided quantities for initial prescriptions and subsequent ones under.

Oklahoma SB1642 modifies the rules for prescribing opioid drugs for acute pain. It limits initial prescriptions to a seven-day supply and allows practitioners to issue subsequent seven-day prescriptions under certain conditions, such as major surgical procedures or home confinement. The bill also mandates discussions between practitioners and patients about the risks and alternatives of opioid use. Additionally, it requires patient-provider agreements for chronic pain prescriptions exceeding three months. The changes become effective November 1, 2026.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

0
2
RR
Democratic CaucusRepublican Caucus

Roll Call Votes

79 Yea

DDDRDRRRRRRRDRRRRRRRRRDDRRRRDDRDRRRRRRRRRRRRRRRRRRRDDDDRRRRRRRRRRDRRRRRRDRRRRRD

0 Nay

20 Absent

DRRRRRRRRDRRRRRRRRRR

Calendar

Apr 15

3:00 PM

House Health and Human Services Oversight Hearing

Apr 8

10:30 AM

House Alcohol, Tobacco and Controlled Substances Hearing

History

May 7

Senate

Becomes law without Governor's signature 05/07/2026

Apr 30

Senate

Enrolled, to House

Apr 30

House

Signed, returned to Senate